First trial of concurrent amyloid and tau immunotherapies in sporadic Alzheimer’s is underway. Safety data are a go for subcutaneous remternetug. Plaque removal correlates with cognitive benefit in ...

All the things that define AD pathogenesis—the seeding and growth of Aβ plaques, withering of surrounding synapses, propagation of tau tangles, and infiltration of circulating immune cells into the ...

Undergraduate in psychology at UFCSPA.

Ph.D., SUNY Downstate Medical Center & NYS Institute for Basic Research, NY, USA. M.D., Aga Khan University, Karachi, Pakistan ...